Business Wire

‘Warmer Together’: Moncler Celebrates Warmth and Love, With Legendary Friends Al Pacino and Robert De Niro

15.10.2025 14:00:00 CEST | Business Wire | Press Release

Share

Over seven extraordinary decades of evolution and innovation, Moncler has become synonymous with warmth, embracing the elements, and year-round performance and style. It’s true the brand was born in the Alps in 1952 with a mission to protect climbers and mountain workers from the extreme cold, but for Moncler, warmth was never about the outside.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015925807/en/

Al Pacino and Robert De Niro star in Moncler’s Warmer Together campaign. Courtesy of Moncler

To manifest that essence, Moncler today unveils the new global statement, Warmer Together, bringing Al Pacino and Robert De Niro together for their first-ever shared campaign.

Warmer Together goes beyond words, it is the heartbeat of Moncler’s purpose. From the very beginning, the brand has known that true warmth is never only in the jackets we wear, it comes from within. It is the warmth of showing up, of looking out for one another, of staying close even in the coldest places. Moncler stands for more than protection from the elements; it stands for connection. Warmer Together is woven into every stitch, a quiet promise to bring people closer, to build bonds, and to remind us that warmth goes beyond insulation. Real warmth is never solitary, it is real when it is shared.

“For decades, Moncler has been associated with winter and puffer jackets, but I have always felt that Moncler is about something deeper: love and a sense of togetherness.
These values have shaped everything we’ve done for over 70 years. Across every product and every campaign, there runs a consistent thread of emotion and human connection.
Through their story of friendship, Al Pacino and Robert De Niro embody everything Moncler truly stands for: affection, warmth, and the belief that we are all better and warmer together.” Remo Ruffini, Chairman and CEO of Moncler

Shot in New York by world-renowned portrait photographer Platon, the Al Pacino and Robert De Niro story unfolds in striking black-and-white images and a suite of short films cut to five themes — Friendship, Respect, Connection, Trust, Warmth — complete with behind-the-scenes moments and the city’s skyline as a recurring motif. Their mutual bond as friends is evident. As they sit together and speak, each man’s energy lifts the other’s presence.

“Warmth was never about the outside. It was always about what was happening on the inside.” So says Robert De Niro in a teaser released ahead of the launch to share the Warmer Together manifesto.

“Friendship is the greatest thing you can have. Friends, people whom you share the same world with. There is just an innate trust. And the understanding of life.” Al Pacino

Moncler is proud to connect with these two great friends, and two greats of cinema, to share its enduring belief in human warmth. Starting today, Moncler brings Warmer Together to life globally across outdoor, press, web and social, followed by a second wave of films and behind-the-scenes moments in the days after.

To accompany Warmer Together, artist and Moncler ambassador Tobe Nwigwe, together with his wife Fat, has recorded a new rendition of Bill Withers’ classic track Lean on Me. A timeless anthem of friendship, support, and solidarity in challenging times, the song’s lyrics echo the campaign’s message of comfort found in companionship. Its accompanying film reflects the campaign’s cinematic spirit and New York backdrop.

Warmth was never about the outside.
It was always about what was happening on the inside.
Warmth comes from the walks and the talks.
From pulling up a chair and having a chat. The caring conversations.
More than the weather,
warmth is, and will always be, about being together,
no matter what.
Warmer Together

Warmer Together Campaign Manifesto

Warmer in the Moncler Maya 70 and Bretagne Jackets

Embodying timeless warmth, Robert De Niro wears the Maya 70 jacket in the Warmer Together campaign, a modern rendition of the original, down-quilted hero jacket and one of the brand’s most iconic and enduring designs. Whether worn for decades or newly discovered, Maya remains a timeless wardrobe staple, deeply embedded in Moncler’s mountain DNA. Crafted from the brand’s signature longue saison recycled nylon, the design’s defining features include a signature logo-adorned pocket on the left sleeve and a detachable hood.

Showcasing the brand’s constant evolution, while remaining true to its roots, the season sheds a spotlight on the Bretagne jacket. New for Fall/Winter 2025, the short, hooded puffer delivers exceptional protection from the elements without sacrificing comfort or freedom of movement. Designed to provide warmth without weight in a cocooning silhouette, the Bretagne is a versatile actor, perfectly suited for outdoor city scenes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251015925807/en/

Contacts

monclerpress@moncler.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye